EVOKE PHARMA, INC.: cash including restricted cash

What this measure means

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

Exact concept: us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2020-12-31 to 2024-12-31. The SEC response was captured on 2026-09-21.

Selected filing history

Related financial histories

• EVOKE PHARMA, INC.: total assets
• EVOKE PHARMA, INC.: total liabilities
• EVOKE PHARMA, INC.: stockholders equity
• EVOKE PHARMA, INC.: cash and cash equivalents
• EVOKE PHARMA, INC.: net income or loss
• EVOKE PHARMA, INC.: operating cash flow
• EVOKE PHARMA, INC.: contract revenue excluding tax
• EVOKE PHARMA, INC.: financing cash flow
• EVOKE PHARMA, INC.: retained earnings or deficit
• EVOKE PHARMA, INC.: basic weighted-average shares
• EVOKE PHARMA, INC.: diluted weighted-average shares
• EVOKE PHARMA, INC.: basic earnings per share
• EVOKE PHARMA, INC.: diluted earnings per share
• EVOKE PHARMA, INC.: share-based compensation expense
• EVOKE PHARMA, INC.: operating income or loss
• EVOKE PHARMA, INC.: current assets
• EVOKE PHARMA, INC.: interest expense
• EVOKE PHARMA, INC.: current liabilities
• EVOKE PHARMA, INC.: operating expenses
• EVOKE PHARMA, INC.: net inventory
• EVOKE PHARMA, INC.: selling, general and administrative expense
• EVOKE PHARMA, INC.: research and development expense
• EVOKE PHARMA, INC.: common shares outstanding
• EVOKE PHARMA, INC.: operating lease right-of-use asset
• EVOKE PHARMA, INC.: other noncurrent assets
• EVOKE PHARMA, INC.: general and administrative expense
• EVOKE PHARMA, INC.: nonoperating income or expense
• EVOKE PHARMA, INC.: proceeds from issuing common stock
• EVOKE PHARMA, INC.: operating lease payments
• EVOKE PHARMA, INC.: change in accounts receivable
• EVOKE PHARMA, INC.: change in inventories

Inspect the source

Entity

EVOKE PHARMA, INC. / CIK 0001403708

Captured

2026-09-21T17:19:23.305Z

SEC response SHA-256

1d2ea0edbbb48066d62d49983dacdd25cf55cdf81e3ee5a742e26303a1f7d06e

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001403708.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))